National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
LY317615

 A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of serine threonine kinase inhibitor. Also called enzastaurin and enzastaurin hydrochloride.

Previous Definitions:luteinizing hormone-releasing hormone, lutetium texaphyrin, Luvox, LY231514, LY293111
Next Definitions:LY335979, LY353381 hydrochloride, lycopene, lymph, lymph gland